Posted in | News | Petrochemicals

ExxonMobil Chemicals Announce the Availability of of More High Viscosity Polyalphaolefins

Nov 30 2009

Related Stories

ExxonMobil Chemical (NYSE:XOM) announced today the availability of an additional 15 thousand tons per year (kta) of high viscosity (Hi Vis) polyalphaolefins (PAO) production. This additional production, achieved through a custom manufacturing arrangement, will help the company meet growing demands for its high-performance PAO fluids.

"SpectraSyn PAO fluids are the core of ExxonMobil Chemical's broad portfolio of synthetic basestocks," said Habib Quazi, Synthetics Global Vice President. "The additional production of these fluids further demonstrates our commitment to grow with our valued customers."

ExxonMobil Chemical is the world's largest PAO producer. The company's high-performance PAO products range from 2 cSt to 1,000 cSt and are part of a comprehensive synthetics basestocks portfolio that includes Synesstic alkylated naphthalenes.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback